Innate lymphoid cells (ILCs) and NK cells have garnered considerable interest due to their unique functional properties in immune defense and tissue homeostasis. Our current understanding of how these develop has been greatly facilitated by knowledge of T cell biology. Models of T cell differentiation provided the basis for a conceptual classification of these innate effectors and inspired a scheme of their activation and regulation. In this review, we discuss NK cell and ILC development from a 'T cell standpoint', in an attempt to extend the analogy between adaptive T cells and their innate ILC and NK cell counterparts.
Introduction
The discovery some 40 years ago of innate cytotoxic cells (natural killer, NK) in mice and man (Kiessling et al., 1975; Herberman et al., 1975) forced immunologists to rethink several concepts about lymphocyte development and function. While similar to cytotoxic T lymphocytes (CTL) in their capacity to eliminate target cells, NK cells differ dramatically in the way they 'sensed' target cells (as they lack a T cell receptor) and in their kinetics of action. Molecular mechanisms that are responsible for this divergence are well described (Raulet and Vance, 2006) . Nevertheless, the immune functions of these two diverse lymphocyte subsets appear analogous, reflecting the conservation of an underlying developmentally-driven process (Sun and Lanier, 2011) .
Comparing 'innate' and 'adaptive' lymphocytes has intensified over the past decade with the discovery of an extended, related family of innate lymphoid cells (ILC). Similar to T cells of the adaptive immune system, ILCs are derived from common lymphoid progenitors (CLP) and display a lymphoid morphology. As is the case with NK cells, ILCs do not express a T-cell receptor (TCR) and do not require recombination machinery in order to mature. ILC function is rather controlled via activation signals in their immediate environment, resulting in copious cytokine production (Morita et al., 2016; Mjösberg and Spits, 2016) . As such, ILCs are thought to play important protective roles in the early immune response against infection and cellular transformation, especially at epithelial barrier surfaces (Neill and Flynn, 2018) . On the other hand, dysregulated ILC function has been implicated in several inflammatory diseases (McKenzie et al., 2014; Sonnenberg and Artis, 2015) .
Three main groups of ILCs have been initially identified having remarkable functional parallels with known helper T (Th) cell subsets (Spits and Di Santo, 2011) . In each case, distinct transcription factors (TF) are expressed as key regulators of the specific cytokine production profiles; this knowledge base had been built upon years of work by T cell immunologists. A unified nomenclature rapidly emerged (Spits et al., 2013) : group 1 ILC (ILC1) were defined as ILCs expressing Tbx21 (encoding the T-box transcription factor, T-bet) and able to produce interferon gamma (IFN-γ) (Bernink et al., 2013; Vonarbourg et al., 2010) , group 2 ILC (ILC2) as ILCs expressing high amounts of Gata3 (encoding the GATA binding protein 3, GATA3) and producing interleukin (IL)-5 and IL-13 (Mjösberg et al., 2011; Moro et al., 2010; Neill et al., 2010; Price et al., 2010) , and group 3 ILC (ILC3) as those expressing Rorc (encoding the RAR-related orphan receptor gamma, RORgt) and producing IL-17A and IL-22 (Cella et al., 2009; Cupedo et al., 2009; Sanos et al., 2009; Satoh-Takayama et al., 2008) . As such, these recently described ILC subsets can be considered as 'innate' versions of adaptive CD4 + Th cells. Comparing these ILC subsets with conventional NK (cNK) cells show remarkable developmental similarities as well as similar rapid effector functions, placing NK cells and ILCs together as a related family of innate effector lymphocytes. Nevertheless, several properties of cNK cells set them apart from other ILC subsets (Daussy et al., 2014; Klose et al., 2014; Robinette et al., 2015) , and rather suggest a distinction between 'helper' ILCs (ILC1, ILC2 and ILC3) and 'cytotoxic' ILCs (NK cells) that parallels the CD4 + Th cells versus CD8 + CTL duality (Artis and Spits, 2015) . The recent identification of intestinal IL-10-producing regulatory ILCs may represent an additional branch of 'helper' ILCs that represent innate versions of IL-10 producing CD4 + T cells (Gabryšová et al., 2018) .
It is clear that the substantial knowledge of mechanisms controlling T cell differentiation and function has been particularly helpful in rapidly advancing our understanding of ILC biology. While an evolutionary relationship between T cells and ILCs still remains speculative , the orchestration of Th cell and ILC subset differentiation is remarkably shared; many TFs previously identified as key regulators in Th cells are now known to be involved in ILC and NK cell differentiation (Fang and Zhu, 2017; Serafini et al., 2015) . We will not attempt to comprehensively re-review these subjects here, but we will rather ask the question: what more can we learn about the process of ILC and NK cell development and function through analogy with the well described pathways of adaptive T cell development? Schematically, the generation of mature ab T cells is achieved through three major stages, several of which occur in the thymus. These include a first step of T lineage commitment, where lymphoid precursors are restricted to the T cell fate. A second step -T lineage choice -selects major histocompatibility complex (MHC) class II-restricted CD4 + and MHC class I-restricted CD8 + T cell lineages that produce naïve T cells that leave the thymus. A final stage of T cell clonal expansion occurs in secondary lymphoid tissues (lymph nodes) and generates functionally specialized Th cells and CTL that participate in adaptive T cell responses and provide immune memory (Figure 1) . In this review, we propose to apply this 'T cell-centric' view to analyze the critical stages of ILC and NK cell differentiation, highlighting the similarities but also discussing the important differences.
Commitment of Lymphoid Precursors to the ILC Fate
CLPs have been shown to have the potential to generate all known lymphocyte subsets (ILC, T, B and NK cells) following in vivo adoptive transfer in mice and using in vitro stromal cell-based growth assays in humans (Kondo et al., 1997) . These multi-potent lymphoid precursors subsequently undergo stepwise restriction to individual lymphocyte cell fates. TFs are proteins able to enhance or inhibit the expression of target genes, and thereby promote certain lymphocyte lineages at the expense of others (Rothenberg et al., 2016) . As such, TFs play a fundamental role in guiding the development and differentiation of the immune cells during hematopoiesis. Intrathymic signals promote this process during T cell development, generating T lineage committed precursors. For the development of ILC subsets and NK cells, core pathways that play analogous roles have been identified ( Figure   2 ). We have previously used the term common ILC precursors (CILCP) to denote lymphoid precursors that have lost B and T cell potential, have no myeloid potential and give rise to the three main ILC groups and cNK cells at the clonal level (Serafini et al., 2015) . CILCP include previously identified C-X-C motif chemokine receptor 6 (CXCR6) + a lymphoid precursors (aLP) and 'early innate lymphoid progenitors' (EILP) Yu et al., 2014) .
T cell factor 1 (TCF-1, encoded by Tcf7) plays a critical role in T lymphocyte development (Germar et al., 2011; Weber et al., 2011) . Tcf7 GFP reporter mice provide the means to isolate EILP from adult mouse bone marrow . (Klose et al., 2014; . More recent work showed that EILPs derive from CLPs (Harly et al., 2018) suggesting that rapid changes in CD127 expression accompany the process of ILC lineage commitment. Interestingly, a similar shutdown of CD127 expression also occurs during entry of early T cell progenitors (ETP) in the thymus (Schlenner et al., 2010) perhaps reflecting receptor occupancy-induced internalization or receptor shedding.
Studies on T cell development have previously shown the critical role for TCF-1 in T lineage specification and commitment from lymphoid precursors (Verbeek et al., 1995) . TCF-1 is a direct target of Notch and over-expressed TCF-1 can rescue thymopoiesis and suppress B lineage development from Notch-deficient ETP (Weber et al., 2011) . This latter point suggests that TCF-1 role in promoting T and ILC development involves, in part, repression of B cell fate. TCF-1 can activate other genes implicated in ILC development such as Gata3 and Bcl11b (encoding the B-cell lymphoma/leukemia 11b protein, BCL11b) (Weber et al., 2011) . Interestingly, these TFs are key drivers of thymopoiesis (Rothenberg et al., 2016) , underlining the commonality of T and ILC lineage commitment mechanisms at the earliest stages when ETPs and CILCPs respectively emerge from CLP (Figure 2 ).
While the role for Notch signaling in CILCP generation is not known, Tcf7 expression in these cells is consistent with transient Notch signaling (Cherrier et al., 2012) during ILC and NK cell lineage commitment. Strength and duration of the Notch signaling, combined with differential concentrations of IL-7, may also be crucial in the commitment towards T cell or ILC. Previous studies have already demonstrated that Notch is crucial for commitment towards a T cell but not a B cell fate (Radtke et al., 1999; Schmitt and Zúñiga-Pflücker, 2002) , and that high Notch amounts are further required for generation of ab T cells, when reduced amounts are sufficient for generation of gd T cells (Washburn et al., 1997) . It is also known that Notch signals are dispensable for generation of NK cells (Radtke et al., 2000) and fetal RORgt + cells (Possot et al., 2011) . However, a recent study suggests that short exposition or intermediary amounts of Notch combined with high amounts of IL-7 in CLPs leads to ILC2 generation, while sustained or high amounts of Notch signaling induces differentiation into T cells (Koga et al., 2018 (Seehus et al., 2015; Geiger et al., 2014; Seillet et al., 2014; Xu et al., 2015; Yu et al., 2014) . Mechanistically, NFIL3 can bind the Tox promoter, and Nfil -/-CLP have decreased expression of Tox . In turn, TOX appears to be crucial for Tcf7 expression downstream of CLP (Seehus et al., 2015) , leading to a NFIL3 ® TOX ® TCF-1 activation cascade (Figure 2 ). Low amounts of NFIL3 in CLPs and high expression of NFIL3 and TOX in CILCPs support such a feed-forward model that can serve to maintain TCF-1 expression in CILCPs, at least during the earliest stages of ILC and NK cell lineage commitment. This cascade appears redundant in T lineage commitment, as Nfil3 deficient mice develop a normal T cell compartment (Xu et al., 2015) . In this later case, sustained expression of TCF-1 is likely maintained through persistent Notch signaling.
As CILCPs further differentiate, expression of the TF Inhibitor of DNA 2 (ID2) cements their commitment towards the ILC fate (Figure 2) . ID proteins (ID1 to ID4) belong to the helix-loop-helix (HLH) family of TFs that act as repressors of E proteins (E2A, E2-2 and HEB) transcriptional activators (Verykokakis et al., 2014) . E proteins potently promote B and T lymphopoiesis and ID2 counteracts this function promoting development of NK cells and lymphoid tissue-inducer (LTi) cells (Heemskerk et al., 1997; Yokota et al., 1999) . Further studies have demonstrated that ID2 is critical for generation of all ILC subsets (Moro et al., 2010; Satoh-Takayama et al., 2010; Cherrier et al., 2012) , reinforcing the notion of ID2 as an essential mechanism for excluding B and T cell fates from (Zook et al., 2018) . Together these studies suggest that ID2 may represent the molecular switch that imprints 'rapid reactivity' in both innate and adaptive lymphocytes. Signals that up-regulate ID2 expression in CILCPs are not fully characterized, although it has been shown that NFIL3 can bind the ID2 promoter in ILC precursors (Xu et al., 2015) .
As ID2 plays a critical role in ILC and NK cell development, ID2 expression offered the means to isolate and characterize early NK and ILC precursors (NKP, ILCP). Using Id2 GFP reporter mice, both CD127 + pre-pro NKP and CD127
been identified (Carotta et al., 2011; Klose et al., 2014) . As expected, ID2 + NKP give rise to mature NK cells in vivo (Carotta et al., 2011) , while ID2 + CHILP can generate ILC1, ILC2, ILC3 and lymphoid-tissue inducer (LTi) cells but not cNK cells in vivo and in vitro (Klose et al., 2014) . It is indeed curious that ID2 + ILCP which can generate both cNK and ILCs have not identified, leading to the suggestion that ID2 might differentially regulate cNK versus ILC fates. Alternatively, current Id2 reporter mice may lack sufficient sensitivity to identify these rare multipotent NK and ILC progenitors. The TF GATA-3 has multiple roles in development of hematopoietic and non-hematopoietic tissues. Within immune cells, GATA-3 is essential for early T cell development and promotes CD4 + T cell lineage choice in the thymus and T helper-2 (Th2) cell differentiation in the periphery (Tindemans et al., 2014) . GATA-3 ablation severely affects development of all ILC subsets (ILC1, ILC2, ILC3) (Hoyler et al., 2012; Serafini et al., 2014; Yagi et al., 2014) but is not essential for cNK development (Samson et al., 2003) . These observations suggest that GATA-3 operates in the ILC lineage (but not the NK lineage) downstream of CILCP to generate CHILP. As such, GATA-3 appears to operate as a central regulator of 'helper' lineage choice in both innate and adaptive lymphocytes.
Previous studies have documented that GATA-3 helps repress B lineage potential in ETPs (García-Ojeda et al., 2013) . This may occur in part through negative regulation of TFs that promote the B lineage program, such as early B-cell factor 1 (EBF-1). Interestingly, EBF-1 promotes B cell differentiation from CLPs via repression of ID2 and TCF-1 (Nechanitzky et al., 2013) documenting the mutual antagonism inherent in the B versus ILC and T pathways.
A similar observation has been made concerning the TF pro-leukemic zinc finger (PLZF, encoded at Zbtb16). Using Zbtb16 GFP reporter mice, a PLZF + ILC precursor population has been identified in fetal liver and adult bone marrow that can give rise to ILC1, ILC2 and NKp46 + ILC3, but has apparently lost potential for LTi cells and cNK cells (Constantinides et al., 2014) . A fraction of CHILP express PLZF (Klose et al., 2014) and GATA-3 is co-expressed in PLZF + ILCP (Constantinides et al., 2014 How 'cytotoxic' NKPs and 'helper' ILCPs are differentially generated is largely unknown, but one may consider analogies with the process of intrathymic CD4 + and CD8 + T cell lineage choice.
In the thymus, DP cells undergoing persistent TCR signaling are thought to upregulate expression of Zbtb7b, the gene coding for the T-helper-inducing POZ/Krüppel-like factor (ThPOK) (Sun et al., 2005) . This zinc finger TF belongs to the same family as PLZF, and works to antagonize Cd4 silencers as well as Cd8 enhancers, and suppresses Runt-related transcription factor 3 (RUNX3) expression that is critical for CD8 lineage choice (Muroi et al., 2008) . The role for ThPOK in ILC development is not known although it is expressed by several ILC subsets. Regulation of Zbtb7c expression (or that of other Zbtb family members) in multipotent NK and ILC progenitors may allow for CHILP versus NKP lineage choice by an analogous mechanism.
In the 'kinetic signaling' model (Singer et al., 2008) , CD4 versus CD8 lineage choice in the thymus is governed by persistence of TCR signals (that promote CD4 + cells) versus cytokine signals (that promote CD8 + cells). The principle downstream target of cytokine signaling at this stage is RUNX3 that orchestrates the 'cytotoxic' lineage gene signature (Singer et al., 2008) , although RUNX1 is also involved (Etzensperger et al., 2017) . Given the important role for RUNX TFs in NK cell development (Ebihara et al., 2015) , it is interesting to postulate a similar cytokine-driven mechanism to drive NKP development from CILCP. Recently, a series of cytokines (IL-6, IL-7, IL-15, IFN-g, TSLP, TGF-b) have been identified that promote CD8 lineage choice in the thymus (Etzensperger et al., 2017 (Figure 2) .
Differentiation of functionally distinct ILC subsets
Following on from our proposed analogy between T cell developmental and ILC and NK cell development, the next step involves the conversion of naïve cells into functional effectors (Figure 1 ).
For the adaptive immune system, this process generates CTL and Th subsets, while for the innate system, NKP and CHILP would give rise to cNK cells and the various different mature ILC subsets (Figure 2) .
The essential TFs that drive the differentiation of 'helper' ILC subsets and 'cytotoxic' NK cells have been fully characterized (Figure 2) . NK cells and ILC1 produce type 1 cytokines (including IFN-γ) in a T-bet-dependent fashion, as Tbx21 -/-mice show cytokine production deficiencies in both these subsets (Klose et al., 2014; Townsend et al., 2004) . T-bet concentration appears to differentially impact NK cell and ILC1 homeostasis since Tbx21 is partially repressed during NK cell development and its over-expression leads to decreased numbers of cNK cells and increased number of ILC1, in particular in the liver (Daussy et al., 2014) . Downstream targets of Tbx21 in NK cells and ILC1
include Runx3 similar to that observed in Th1 cells (Djuretic et al., 2007) . Indeed, RUNX3 expression is essential for generation of T-bet + NK cells, ILC1 and NKp46 + ILC3 (Ebihara et al., 2015) .
In addition to T-bet, cNK cells require several additional TFs that are not shared with ILC1.
One such factor required for cNK cell development is Eomesodermin (EOMES), that is already expressed in NKPs (Male et al., 2014) but not in ILCPs. In Eomes
Vav Cre/+ mice, NKPs fail to mature, identifying EOMES as a positive critical regulator of cNK cell differentiation, whereas other ILC subsets are unaffected (Gordon et al., 2012; Klose et al., 2014) . Other NK cell-specific TFs include the Zinc finger E-box-binding homeobox 2 (ZEB2) and the TF SMAD4 (Cortez et al., 2017; van Helden et al., 2015; Robinette et al., 2015) . In NK cells, Zeb2 is induced by T-bet, and is required for NK cell maturation and egress of the bone marrow through expression of the lysosphingolipid sphingosine 1-phosphate (S1PR5) (van Helden et al., 2015) . Deficiency of SMAD4, on the other hand, lead to specific loss of CD49b + cNK cells in the bone marrow and in peripheral organs, although the underlying mechanisms are not fully understood (Cortez et al., 2017) .
Concerning ILC2 differentiation, key TFs that drive this process include RORα, TCF-1, BCL11b and GATA-3 (Califano et al., 2015; Hoyler et al., 2012; Klein Wolterink et al., 2013; Walker et al., 2015; Wong et al., 2012; Yu et al., 2015) . A mechanistic understanding of how these TFs promote ILC2 differentiation has not yet been obtained, although T cell research again may provide some clues. As previously mentioned, TCF-1 is a Notch target in ETP, and can induce Gata3 and Bcl11b expression (Weber et al., 2011) . High amounts of TCF-1 in ILC progenitors may predispose to ILC2 differentiation by priming Gata3 and Bcl11b promoters. GATA-3 transcriptionally activates type two cytokines, due to its ability to bind to the Il5 and Il13 promoters (Zhang et al., 1997) (Figure 2 ). In contrast, BCL11b appears to influence ILC2 differentiation through regulation of Il17rb (IL-25R) expression (Yu et al., 2016) . Together, these TFs coordinate expression of ILC2-specific effector functions and responsiveness to ILC2-dependent homeostatic cytokines thereby assuring productive ILC2 differentiation.
RORγt is essential for generation of all group 3 ILCs produced during fetal and adult life (Cording et al., 2014) . Rorc can be activated via retinoic acid (RA) receptor signaling in utero as well as in adult mice (van de Pavert et al., 2014) . RORγt can subsequently interact with SRC family coactivators and bind DNA for transcription activation (Ciofani et al., 2012) , while RA signals ensure later migration to the gut by activating expression of gut-homing receptors such as C-C motif chemokine receptor 9 (CCR9) (Kim et al., 2015) . The role for RORγt in ILC3 differentiation appears similar to that operating during Th17 cell polarization. Indeed, RORγt mutations that cripple Th17 polarization (following failure of Lys69 ubiquitination) also induce loss of LTi-dependent Peyer's patches (He et al., 2017) .
ILC Differentiation: when and where?
While the TF mechanisms driving ILC and NK cell differentiation are being unraveled with increasing depth (Fang and Zhu, 2017; Serafini et al., 2015; Zook and Kee, 2016) , our knowledge of when and where this process occurs remains unclear. The longstanding dogma states that NK cells are generated in the adult bone marrow (Kim et al., 2002) , however, the presence of NKPs in the circulation and in tissues suggested an alternative model (that we termed 'NK-poiesis') whereby immature NKPs would complete their differentiation outside the bone marrow (Di Santo, 2008) . More recently, circulating and tissue-resident human ILC precursors have been characterized that have the potential to generate all human ILC subsets as well as cNK cells . These cells have properties in common with multi-potent CD34 + RORγt + ILC precursors previously identified in human tonsils (Scoville et al., 2016) . Human ILCPs are small resting lymphocytes and lack the functional outputs of mature ILC or NK cells, although they are clearly ILC and NK cell lineage committed, with expression profiles of innate lymphocytes (ID2, TOX, CD127). Additional epigenetic analysis demonstrates that these cells are poised for further differentiation, suggesting that human ILCPs were 'naïve' . The identification of a circulating human ILCP suggests that ILC differentiation might be possible outside of the bone marrow, prompting us to propose the term 'ILC-poiesis' which described the process of ILC generation in tissues in response to local inflammatory signals (Di Santo et al., 2017; Lim et al., 2017) .
The proposed processes of 'NK-poiesis' and 'ILC-poiesis' are inspired by existing models of T cell differentiation in the adaptive immune system (Figure 1) . In all cases, naïve cells that lack effector functions are activated to mature into functionally competent cells that can participate in immunity. For T cells, this process takes place in secondary lymphoid organs (lymph nodes, Peyer's patches) and involves antigen presentation by mature dendritic cells that triggers specific TCRs The 'NK-poiesis' and 'ILC-poiesis' models provide a mean for rapid and precisely localized immune responses. As the 'naïve' innate lymphocyte equivalents are free to circulate throughout the organism, any local stress or inflammation that is associated with infection or transformation would trigger the process of NK cells and ILC differentiation where it is required. The local response by sentinel cells and stroma will vary depending on the nature of the inciting pathogenic event; as such, the generation of the appropriate ILC or NK cell response would be 'tuned' to the environment. The 'on demand' nature of 'NK-poiesis' and 'ILC-poiesis' is therefore coordinated in time and space.
The requisite influence of environment on the type of NK cell and ILC subset generated in 'NK-poiesis' and 'ILC-poiesis' models offer the means to understand some peculiar aspects of NK cell and ILC biology. For example, NK cells and ILC subsets are differentially repartitioned throughout the organism (Chea et al., 2015; Simoni et al., 2017) , yet the precise mechanisms driving this are still poorly understood (Figure 3) . This can be partly explained by effects of temporal seeding during embryogenesis , by organ-specific expression of chemokines receptors and integrins on polarized ILCs , or by maintenance signals . Moreover, mature ILCs are proposed to be tissue-resident cells (Gasteiger et al., 2015) , with little or no capacity for migration, although this may change upon inflammation (Huang et al., 2018) .
The additional concept of generation of NK cells and ILC subsets from 'naïve' precursors in tissues in response to environmental signals may help explain tissue-specific differences in ILC and NK cell homeostasis. For example, adult bone marrow is rich in NK cell and immature ILC2, whereas ILC3
are rare (Hoyler et al., 2012; Sawa et al., 2010) . In contrast, fetal and adult gut strongly promote ILC3 development with little or no NK cell generation (Bando et al., 2015; Cherrier et al., 2012; Klose et al., 2014) . How different tissue environments program specific NK and ILC outputs under steadystate conditions remains unclear but are likely to be a recapitulation of what occurs in the context of infection and inflammation.
Fetal vs. adult ILC development
Tissue-specific ILC development occurs in utero in the fetal liver. This process partly resembles ILC development in the adult bone marrow with the generation of Id2-and Zbtb16-expressing CHILPs (Constantinides et al., 2014; Klose et al., 2014) as well as Arginase-1 (Arg-1)-expressing CILCPs (Bando et al., 2015) . Fetal liver also harbors NKPs able to differentiate into NK cells in vitro (Tang et al., 2012) . It therefore appears that the first two stages of ILC and NK cell development (generation of CILCPs, generation of CHILPs and NKPs) occur early in life during the fetal period. Interestingly, fetal liver also contains a predominant ILC3 precursor that expresses the TF RORγt and the LTi surface marker CD4 (Cherrier et al., 2012; van de Pavert et al., 2014; . These RORγt + progenitors give rise to CD4 + LTi cells that migrate to the gut to initiate Peyer's patch development, and also generate IL-22 producing NKp46 + ILC3 .
NK1.1 + cells that resemble adult hepatic ILC1 are also present in the fetal liver (Tang et al., 2012) suggesting that this tissue is selectively permissive for ILC1, ILC3 and NK cell development. In contrast, fetal gut and fetal mesentery harbors ILC2 and ILC3 but few ILC1 or NK cells (Bando et al., 2015; Koga et al., 2018) . Interestingly, fetal mesentery also contains PLZF + ILCP, and might thus act as an intermediary site or reservoir for early ILC development (Koga et al., 2018) .
The relative importance of fetal versus adult ILC production is largely unknown. Although fetal ILCs are critical for the generation of Peyer's patches in the gut (Eberl et al., 2004) , their contribution to the adult ILC3 pool is less clear. While adult ILCs appear tissue-resident (Gasteiger et al., 2015; Huang et al., 2018) , ILC3 derived from fetal and perinatal RORγt + precursors persist for about 8 weeks (Figure 3) . Fetal ILC and NK cell waves may nonetheless play an important role in tissue remodeling and immune protection. Renewal of ILCs in some tissues indicate that cells are recruited throughout adult life (Huang et al., 2018) , perhaps through rare seeding of bone marrow ILCP and subsequent 'ILC-poiesis'. These different mechanisms likely work together to maintain ILC homeostasis in peripheral tissues of adult animals.
Role of the environment in ILC maintenance and plasticity
ILC activation in peripheral tissues relies on a 'cross-talk' with stromal and other immune cells. IL-33, for example, is a potent ILC2 activator, and can be produced by immune cells including mast cells or macrophages, as well as necrotic cells (Chang et al., 2011; Lüthi et al., 2009; Shimokawa et al., 2017) . IL-1β and IL-23, on the other hand, induce activation of ILC3 and can be produced by macrophages or dendritic and epithelial cells, respectively (Macho-Fernandez et al., 2015; Mortha et al., 2014) . These activating cytokines appear important for ILC homeostasis in peripheral tissues. For example, deficiencies in Il33 or in its receptor reduce ILC2 numbers in the lung (Stier et al., 2018) .
In addition to subset-specific signals, sustained IL-7 and IL-15 produced by non-hematopoietic cells is essential for the maintenance of CD127 + ILCs and NK cells respectively, even after development Schluns et al., 2004; Yang et al., 2018) . Stromal cells can also release metabolites (oxysterols) sensed by G-protein coupled receptors on ILCs that can exert a chemotactic effect; this has been shown to allow ILC3 to cluster within cryptopatches (Emgård et al., 2018) .
Together, these data reveal the important role of environmental signals in coordinating ILC homeostasis within tissues. How this is achieved mechanistically is unclear, but it is known that gut ILC3 do not require bacterial adherence to the epithelium to be affected by microbial signals (Atarashi et al., 2015) . Microbiota may indirectly affect ILCs, via modulation of other immune cells or epithelial cells. Intestinal flora drives cytokine expression within epithelial cells that can activate or repress gut ILC3 activity (Mortha et al., 2014; Sawa et al., 2011) . Sensing of bacterial elements by other immune cells, including macrophages, can as well be involved in ILC3 activation (Mortha et al., 2014) .
Alternatively, microbiota may directly impact on ILC3s via the metabolites it produces; for example, butyrate modifies CCR6 + ILC3 and NKp46 + ILC3 homeostasis in a context-dependent fashion in the gut (Kim et al., 2017) .
Dietary metabolites can also have a direct impact on tissue ILC homeostasis. NKp46 + ILC3
subsets highly express the aryl hydrocarbon receptor (AHR), a TF that can be bound and activated by plant-derived polyphenols (Kiss et al., 2011) . Deletion of this TF induces increased apoptosis in NKp46 + ILC3s but not in other ILC subsets (Qiu et al., 2012) , and administration of a diet devoid of phytochemicals to mice reduces ILC3 number and proliferation in the gut (Kiss et al., 2011) . In a similar manner, vitamin A deficiencies have been shown to induce type 2 immunity and to modify the balance between ILC2 and ILC3, probably due to a lack of signaling through the RA receptor that is expressed in ILC3s but not in ILC2s . Together, these data reveal an important role of dietary metabolites in preserving the ILC homeostatic balance in the gut.
Stability and Plasticity of ILC Effector Functions
While extracellular cues (including cytokines) condition the initial differentiation of NK cells and ILC subsets, additional signals are required to maintain a stable effector phenotype thereby restricting functional plasticity (Figure 4 ). This may be achieved through pioneer TF creating transcriptional cascades with inherent stability as it is the case with T-bet and RUNX3, or TCF-1 and GATA-3 (Djuretic et al., 2007; Weber et al., 2011) . Alternatively, cross-inhibition of TF targets may stabilize effector phenotypes as it is the case for GATA-3 in ILC2 that binds the Rorc locus, inhibiting its expression and preventing up-regulation of ILC3-associated genes (Wei et al., 2011; Zhong et al., 2016) . In Th2 cells, Th1-associated gene repression appears to be dependent for most of the genes on the formation of a complex between GATA-3 and BCL11b (Fang et al., 2018) , and one can reasonably think that a similar complex occurs in ILC2 to suppress ILC1 signatures.
Despite subset-specific TF expression and apparently stable chromatin modifications, ILC subsets can show remarkable plasticity under appropriate circumstances (Figure 4) . ILC3 may be the most plastic cells of their family, similar to Th17 cells (Stockinger and Omenetti, 2017) . In mice, CCR6 -NKp46 -ILC3 up-regulate NKp46 expression after IL-12 induced T-bet activation (Rankin et al., 2013) , eventually losing expression of the subset-specific TF RORγt to become so-called "ex-ILC3 ILC1" (Vonarbourg et al., 2010) . Interestingly, group 3 to group 1 plasticity can lead to pathology, as depletion of these plastic cells could reduce severity of induced colitis, mirroring the detrimental role of "ex-Th17 Th1 cells" (Buonocore et al., 2010; Jostins et al., 2012; Vonarbourg et al., 2010) . Of note, expression of NKp46 appears to be reversible in ILC3, and controlled by a balance between Notch and TGF-β signaling (Verrier et al., 2016; Viant et al., 2016) . In humans, plasticity between group 1 and group 3 has been observed with IL-12 inducing IFN-γ production in ILC3 and IL-1β and IL-23 inducing IL-22 in ILC1 (Bernink et al., 2015) .
ILC2 can also exhibit functional plasticity (Figure 4) . Under stimulation with IL-12, ILC2
express IFN-γ, in both mouse and human models (Bal et al., 2016; Lim et al., 2016; Ohne et al., 2016) .
ILC2 plasticity can moreover by primed by IL-1β signaling. Indeed, this potent ILC2 activator also induces low amounts of Tbx21 and Il12rβ, making ILC2 more susceptible to extra-cellular signals driving plasticity (Ohne et al., 2016) . Similarly, murine ILC2 can acquire IL-17-producing capacity after IL-25 treatment, thus contributing to clearance of fungal infections (Huang et al., 2015) . In these cases, 'plastic' ILC2 retain IL-13 expression, indicating that they only partially switch their phenotype. With the recent description of IL-9 producing ILC2 (Rauber et al., 2017) , these data suggest very similar plastic properties between ILC et Th cell subsets (Murphy and Stockinger, 2010) .
Still, ILC1 and ILC2 are relatively stable subsets (compared to ILC3) due to GATA-3 auto-activating loop and mutual exclusion between T-bet and GATA-3 (Hwang et al., 2005; Ouyang et al., 2000) .
This may also explain why plastic ILC2 do not completely lose type 2 properties.
Epigenetic states control ILC functional stability and plasticity. The VHL E3 ubiquitin ligase targets H3K4 tri-methylation (a permissive chromatin status) of the Ilrl1, Il5 and Gata3 genes , thus maintaining ILC2 in a 'ready-to-go' state. In NK cells, the long non-coding RNA Rroid operates similarly to control H3K27 acetylation and H3K36 tri-methylation at the Id2 locus maintaining NK cell homeostasis by limiting apoptosis (Mowel et al., 2017) . In contrast, deficiency in the lysine methyltransferase G9a induces a decrease in ILC2, due to permissive methylation near genes generally associated with ILC3 such as Rorc, Il22 and Il17f (Antignano et al., 2016) and subsequent ILC3 fate conversion. Taken together, these data indicate analogous roles for epigenetics in ILCs and in T cells, where histone modifications are known to be crucial for balancing naïve T cell polarization and ensuring subset maintenance (Wilson et al., 2009) , through shared ILCs and Th cell regulome signatures (Koues et al., 2016; Shih et al., 2016; Sciumè et al., 2017) . Il10 expression in lung ILC2 (Seehus et al., 2017) . In culture, IL-2 and RA act synergistically to potentiate IL-10 release by ILC2, while TGF-β displays an inhibitory effect (Maroof et al., 2008) .
Recently, a regulatory ILC subset has been described . This CD127 + CD90 + CD25 + population is detected in the small and large intestine, expresses IL-10 but lacks Rorc or Gata3 expression. ILCreg fail to express Foxp3 but their development requires ID3.
Interestingly, ID3 is expressed in differentiated Treg cells (Maruyama et al., 2011) and is also overexpressed in IL-10-producing ILC2 (Seehus et al., 2017) . The biological roles for regulatory ILCs remain unclear but these cells appear to have potent capacity to suppress intestinal inflammatory responses in vivo .
Concluding remarks
Over the past 10 years, our in-depth knowledge of T cell differentiation allowed for an 
